News Category
A small German study found that a new therapeutic vaccine kept two-thirds of patients with aggressive brain tumors alive eight years after enrollment,...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138, a therapy targeting miR-10b in advanced solid tum...
Creative BioTherapeutics has been nominated for the 2026 Prix Galien USA Best Startup award, highlighting its preclinical efforts to address cancer re...
A recent clinical trial of an experimental vaccine has extended survival in glioblastoma patients, signaling potential progress after more than 20 yea...
As GLP-1 weight-loss drugs like Ozempic and Wegovy gain popularity, facial volume loss—dubbed 'Ozempic face'—is driving interest in non-surgical rejuv...
New screening technologies are enabling earlier and more personalized breast cancer detection, which could significantly improve survival rates and bo...
VERAXA Biotech's BiTAC-ADC platform demonstrated significant tumor regression and a differentiated safety profile in preclinical studies, potentially ...
A UK study has identified a potential method to halt lung cancer in its early stages by eliminating 'immune fog,' but residual cancer in some mice sug...
VERAXA Biotech presented promising preclinical data for its BiTAC-ADC platform, demonstrating significant tumor regression and a differentiated safety...
A new study reveals a tumor-suppressive axis involving SPRED2, p53, and miR-506-3p that controls cancer stem cell traits in hepatocellular carcinoma, ...
A new modeling analysis presented at the American Heart Association's Hypertension Scientific Sessions 2026 found that improving high blood pressure c...
Flu infections are rising early across the U.S., prompting health authorities to urge early vaccination and highlighting a potential gap in community-...
Consultwebs is providing a $50 stipend and half-day paid time off to employees who get a mammogram in 2026, part of the EmployersThinkPink initiative ...
A new grant-funded initiative will deploy a digital navigation platform to provide metastatic breast cancer patients with personalized education and s...
The American College of Radiology now recommends women get a formal breast cancer risk assessment by age 25, emphasizing earlier personalized screenin...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to reduce animal testing in preclinical research, potentially accelerating clini...
Lantern Pharma has received regulatory and IRB approvals in Taiwan to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially accelerating de...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing and accelerate clinical advancement of i...
Telomir Pharmaceuticals (NASDAQ: TELO) has raised approximately $5.6 million in a private investment in public equity (PIPE) financing, with proceeds ...
A new study reveals lymph-node-like structures in the skull's bone marrow, suggesting the brain has a local immune defense system that could open new ...
Kairos Pharma's ENV-105 combined with apalutamide significantly improved progression-free survival in metastatic castration-resistant prostate cancer,...
GeoVax will showcase its next-generation MVA vaccine and manufacturing innovations at a major European vaccine conference, potentially transforming ou...
The Hong Kong Convention and Exhibition Centre hosted 786 events in the 2025-2026 financial year, attracting over 7.7 million attendees and securing m...
NHS England has introduced a groundbreaking brain tumor test that provides genetic results in about two hours instead of eight weeks, potentially acce...
A new approach using blood samples to identify cancer-specific proteins could simplify the development of personalized immunotherapies, but further cl...
A new projection warns that more than three million UK children will become short-sighted by age 18, highlighting the need for early eye tests and cor...
Mega Bee Rescues & Pest Control is turning its signature yellow bee pink for October and donating 5% of its pest control and bee removal services to s...
Blue Faery's free HCC Lunch & Learn on October 24 at University of Chicago Medicine aims to improve liver cancer outcomes through education on prevent...
A board-certified vascular surgeon in Clifton, New Jersey, is using laser therapy to treat venous lake, a benign vascular lesion that many patients mi...
Onco-Innovations advances its preclinical oncology candidate ONC010 with a 300-gram API scale-up, a manufacturing partnership, and CAD$5 million in in...
A new report reveals that billions of pounds of chemicals suspected of causing breast cancer entered the U.S. environment in 2020, raising concerns ab...
BIOT's non-exclusive appointment by CelSiege Biosciences to represent the IN01 cancer immunotherapy in Japan and China signals a strategic push to add...
Nashville Concierge Medicine's new content explains how adult ADHD can disrupt sleep and daily focus, urging evaluation and physician consultation.
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate beyond discovery, planning final candidate engineering and preclinical studies...
Nutriband Inc. CEO Gareth Sheridan is featured in a new documentary by Nick Shirley examining the U.S. opioid crisis, highlighting the company's AVERS...
The CDC's report of likely sustained Clade Ib mpox transmission in the U.S. underscores the need for vaccine preparedness, prompting GeoVax to advance...
Novogenia AG's H1 2026 revenue fell 7% to EUR 25.7 million, but growth in its core DNA analysis segment and cost reductions signal progress amid strat...
Scientists in South Korea have identified a new protein that regulates the growth of glioblastoma, the deadliest form of brain cancer, potentially lea...
TransCode Therapeutics announced updated Phase 1a results showing that 71.4% of efficacy-evaluable patients achieved stable disease with its lead cand...
Dr. Amar Surdhar, founder of Clarion Psychiatry, has announced his support for the HAS Foundation, highlighting the need for science, innovation, and ...
VERAXA Biotech is advancing its oncology pipeline and seeking industrial partnerships after completing its business combination and Nasdaq listing, ac...
The increasing personalization of cancer treatments, driven by immunotherapies and other innovations, is making cancer care more complex for patients ...
Creative Biolabs has broadened its specialized antibody offerings for HIV-1, HIV-2, and HTLV-1, providing researchers with new tools to study viral pr...
Quantum BioPharma is developing Lucid-MS, a drug candidate that targets an enzyme to inhibit demyelination, offering a new approach to treating multip...
Kairos Pharma's President and Chief Scientific Officer will present and moderate at a major drug discovery conference, highlighting the company's stra...
A new international study finds that waist-to-height ratio is a reliable, low-cost screening tool for pediatric MASLD across diverse ethnic and geneti...
VERAXA Biotech (NASDAQ: VRXA) is advancing its oncology pipeline centered on the BiTAC platform, following its NASDAQ listing and key executive appoin...
Quantum BioPharma is developing Lucid-MS, a drug candidate that targets an enzyme to inhibit demyelination, offering a potential new path for multiple...
